Skip to main content

Vanda Pharmaceuticals Inc.

VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001347178

No open-market purchases or sales by Vanda Pharmaceuticals Inc. insiders were filed in the last 90 days; 172 institutions reported holding it in 13F filings for Q2 2026, worth $304.1M in total; no superinvestor holds it.

Superinvestors holding VNDA, Q2 2026

See all superinvestors

No superinvestor reported holding VNDA in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of VNDA each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q3 2021

    0 superinvestors holding at quarter end

    Sold out
    Maverick Capital
  2. Q2 2021

    1 superinvestor holding at quarter end

    Reduced
    Maverick Capital (−12.9%)